Lopinavir is an essential protease inhibitor used in antiretroviral therapy to manage HIV-1 infection. It works by blocking the enzyme that the virus needs to replicate, helping to maintain a lower viral load in the body. It is a critical component in trusted, cost-effective generic formulations often combined with other agents. Our pharmacy ensures secure access to quality treatments containing Lopinavir for long-term health management.
Lopinavir belongs to a group of medicines known as protease inhibitors. It is an active ingredient that helps stop a virus from multiplying inside the body. In the United Kingdom, lopinavir is most commonly found in the combination product Kaletra.
The primary product that includes lopinavir is Kaletra. Kaletra is supplied as a fixed-dose tablet that also contains a small amount of ritonavir, which boosts lopinavir’s effectiveness. An oral liquid formulation is also available for people who have difficulty swallowing tablets. In the UK, Kaletra is marketed under its brand name, but the same combination can be obtained as a generic preparation when a prescription is written. The tablets are usually supplied in strengths of 100 mg/25 mg per tablet (lopinavir/ritonavir), while the liquid provides an equivalent dose in a measured spoonful.
Lopinavir is used as part of a combination regimen to treat HIV-1 infection. It works together with other antiretroviral medicines to keep the virus at low levels, helping the immune system stay stronger. The main situations where lopinavir-containing products are prescribed include:
These uses are approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and are reflected in clinical guidelines for the treatment of HIV.
Lopinavir stops a viral enzyme called protease from cutting up large protein pieces that the virus needs to become fully functional. By blocking this step, the virus remains in an immature form that cannot infect new cells. The result is a slower rise in viral numbers, giving the immune system a better chance to control the infection. Effects are generally seen within a few weeks of starting therapy, although the full benefit depends on taking the medication exactly as prescribed.
These reactions are typically short-lived and do not require medical attention unless they persist.
If any of these occur, seek emergency medical help immediately.
Lopinavir can interact with other medicines that affect the liver enzyme CYP3A4. Common interaction groups include certain antifungal agents, antibiotics, and seizure medications. Alcohol may increase the chance of liver irritation, and high-fat meals can alter how much of the drug is absorbed. For a complete list of possible interactions, refer to the specific medication page for Kaletra or speak with a pharmacist.
Store Kaletra tablets and oral liquid at room temperature, away from excess moisture and direct sunlight. Keep the liquid in a tightly sealed bottle and discard any unused portion after the expiry date printed on the label. Treatment duration varies; some people use lopinavir-containing regimens for many years, while others may stop after achieving viral suppression under medical guidance. Always follow the specific instructions that come with your prescribed product and keep the packaging for future reference.
This article provides general educational information about lopinavir as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it may be used to treat. It is not a substitute for professional medical advice or for the specific instructions that accompany individual products. Medicines containing lopinavir can differ in formulation, strength, and directions for use. Always refer to the labeling of your particular medication and follow the guidance of your healthcare provider for complete information on proper use, dosage, and safety.
